Insighht on USFDA approval of Trikafta
Vertex Pharmaceuticals received approval from the U.S. Food and Drug Administration (FDA). This is a landmark approval where Vertex’s Trikafta earned this... Read More
Alexion acquisition of Achillion: A 1 Billion Pharma Strategic Deal
Posted on21 Oct 2019
TagsAchillion, acquisition in pharma, Alexion Pharmaceuticals, global pharma deals, pharma deal, pharma strategic deal
Comments0
Achillion focuses on the development of oral small-molecule Factor D inhibitors to treat people with rare diseases affecting the ‘complement system’, such... Read More
New Drug Approval Case Study: USFDA approval of Galderma’s Aklief cream
US Food and Drug Administration (FDA) approved Galderma’s Aklief (trifarotene) cream, 0.005% for the topical treatment of acne. Aklief Cream is the... Read More
What is indication splitting licensing in pharmaceutical and bio-pharmaceutical business?
Posted on30 Sep 2019
Comments0
While licensing in pharmaceutical and bio pharmaceutical business, if licenses are issued to different partners based on indications or disease and therapy,... Read More
Pharma acquisition case study: Lundbeck to acquire Alder BioPharmaceuticals for US$ 1.95 billion
H. Lundbeck A/S (Lundbeck) and Alder BioPharmaceuticals (Alder) announced a definitive agreement for Lundbeck to acquire Alder. About the deal: Under the... Read More
Mitsubishi Tanabe Pharma, Daiichi Sankyo enters licensing agreement for ALS treatment agent edaravone in Brazil
Posted on18 Sep 2019
Comments0
Mitsubishi Tanabe Pharma Corporation and Daiichi Sankyo announced that they have concluded a licensing agreement covering commercialization rights in Brazil for an... Read More
GSK to acquire Celiac-Focused Sitari Pharmaceuticals
GlaxoSmithKline will acquire San Diego-based Sitari Pharmaceuticals and its transglutaminase 2 small molecule program for celiac disease. Sitari, a preclinical-stage biotech, is... Read More
Pharma brand acquisition case study: Amgen to acquire Celgene’s Otezla
Amgen announced today that it has entered into an agreement with Celgene Corporation in connection with its previously announced merger with Bristol-Myers... Read More
Case Study : Rituxan – A Brand which Pharma Industry reckon
Brand Name: Rituxan Company: Roche 2017 U.S. sales: $4.41 billion Disease: Blood cancers, rheumatoid arthritis Dosage form: Injection for Intravenous Use Rituxan (rituximab) is a... Read More
Case Study: Gilead and Galapagos – R&D collaboration
Posted on15 Jul 2019
Comments0
Gilead Sciences, Inc. and Galapagos NV have entered into a 10-year global research and development collaboration. Through this agreement, Gilead will gain... Read More